Senti Biosciences Holdings (SNTI) Current Leases (2021 - 2025)
Senti Biosciences Holdings (SNTI) posted quarterly Current Leases of $5.3 million for Q4 2025, up 14.7% year-over-year from $4.6 million in Q4 2024, and up 3.43% quarter-over-quarter from $5.2 million in Q3 2025.
Senti Biosciences Holdings (SNTI) Current Leases (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings' Current Leases history runs 5 years deep, the most recent figure standing at $5.3 million for Q4 2025.
- In Q4 2025, Current Leases rose 14.7% year-over-year to $5.3 million; the TTM figure through Dec 2025 stood at $5.3 million (up 14.7% YoY), while the FY2025 annual figure was $5.3 million, up 14.7% from the prior year.
- Current Leases for Q4 2025 stood at $5.3 million, up from $5.2 million in the prior quarter.
- The five-year high for Current Leases was $5.3 million in Q4 2025, with the low at $95000.0 in Q2 2023.
- The 5-year median for Current Leases is $4.0 million (2023), against an average of $3.2 million.
- The sharpest annual moves came in 2023 and 2025: Current Leases tumbled 94.88% in 2023, then soared 4829.7% in 2025.
- Senti Biosciences Holdings' Current Leases stood at $1.7 million in 2021, then rose by 10.27% to $1.9 million in 2022, then surged by 109.73% to $4.0 million in 2023, then advanced by 15.28% to $4.6 million in 2024, then increased by 14.7% to $5.3 million in 2025.
- Business Quant data shows SNTI's Current Leases at $5.3 million in Q4 2025, $5.2 million in Q3 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Senti Biosciences Holdings | 12.66 Mn | 12.66 Mn | - | 3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 4.98 Mn |
| Mar 31, 2025 | 4.81 Mn |
| Dec 31, 2024 | 4.65 Mn |
| Sep 30, 2024 | 4.49 Mn |
| Jun 30, 2024 | 101,000.00 |
| Mar 31, 2024 | 4.18 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Sep 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 95,000.00 |
| Mar 31, 2023 | 2.06 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Dec 31, 2021 | 1.74 Mn |